We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.04B
AUM Growth
+$368M
Cap. Flow
+$68.3M
Cap. Flow %
1.69%
Top 10 Hldgs %
14.84%
Holding
1,360
New
108
Increased
584
Reduced
484
Closed
87

Sector Composition

Rank Sector Weight
1 Technology 14.01%
2 Healthcare 12.17%
3 Financials 11.3%
4 Consumer Discretionary 8.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDL icon
751
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.85B
$640K 0.02%
19,630
+2,274
+13% +$72.4K
IWB icon
752
iShares Russell 1000 ETF
IWB
$50.2B
$640K 0.02%
3,585
-29
-0.8% -$4.95K
IWY icon
753
iShares Russell Top 200 Growth ETF
IWY
$16.5B
$640K 0.02%
6,627
-715
-10% -$65.3K
PWV icon
754
Invesco Large Cap Value ETF
PWV
$1.78B
$640K 0.02%
15,486
-1,058
-6% -$42.2K
FPE icon
755
First Trust Preferred Securities and Income ETF
FPE
$6.34B
$634K 0.02%
31,568
+4,469
+16% +$88.9K
MDIV icon
756
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$428M
$634K 0.02%
33,720
+5,053
+18% +$93.3K
SMAR
757
DELISTED
Smartsheet Inc.
SMAR
$632K 0.02%
+14,061
New +$581K
CCD
758
Calamos Dynamic Convertible & Income Fund
CCD
$741M
$630K 0.02%
29,789
+2,626
+10% +$54.4K
FDUS icon
759
Fidus Investment
FDUS
$753M
$630K 0.02%
42,480
-216
-0.5% -$3.25K
CROX icon
760
Crocs
CROX
$6.63B
$627K 0.02%
+14,965
New +$523K
MFA
761
MFA Financial
MFA
$919M
$627K 0.02%
20,500
SAM icon
762
Boston Beer
SAM
$1.86B
$622K 0.02%
1,646
+904
+122% +$340K
FTSL icon
763
First Trust Senior Loan Fund ETF
FTSL
$2.33B
$617K 0.02%
12,868
+409
+3% +$19.4K
PHO icon
764
Invesco Water Resources ETF
PHO
$2.09B
$616K 0.02%
15,947
-100
-0.6% -$3.71K
AWF
765
AllianceBernstein Global High Income Fund
AWF
$870M
$612K 0.02%
50,469
+5,900
+13% +$70.8K
OPTU
766
Optimum Communications Inc
OPTU
$306M
$607K 0.02%
22,215
+10
+0% +$276
IYF icon
767
iShares US Financials ETF
IYF
$4.4B
$602K 0.01%
8,744
+1,332
+18% +$88.4K
EIX icon
768
Edison International
EIX
$26.1B
$601K 0.01%
7,971
-460
-5% -$32.5K
KR icon
769
Kroger
KR
$34.6B
$599K 0.01%
20,666
+241
+1% +$6.39K
LSXMK
770
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$598K 0.01%
16,320
+456
+3% +$15.9K
TEN
771
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$598K 0.01%
45,620
+565
+1% +$7.41K
PGX icon
772
Invesco Preferred ETF
PGX
$3.76B
$596K 0.01%
39,730
+7,300
+23% +$109K
IYR icon
773
iShares US Real Estate ETF
IYR
$4.52B
$594K 0.01%
6,379
-274
-4% -$25.4K
PXH icon
774
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.98B
$593K 0.01%
+26,575
New +$560K
ROK icon
775
Rockwell Automation
ROK
$48.3B
$591K 0.01%
2,914
+174
+6% +$32.2K

Similar funds

Oppenheimer & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Oppenheimer & Co held 1,360 positions worth $4.04B, up 10% from $3.67B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer & Co's Q4 2019 filing shows 108 new, 584 increased, 484 reduced and 87 closed positions. Its largest new stake was CAE Inc. Common Shares: 78,310 shares worth $2.07M. The largest sale was Celgene Corp, an estimated $6.53M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q4 2019 buy was CAE Inc. Common Shares: 78,310 shares worth $2.07M.
  • Oppenheimer & Co added most to DocuSign in Q4 2019, an estimated $4.67M increase.
  • Oppenheimer & Co's biggest Q4 2019 reduction was Apple, cutting an estimated $5.68M.
  • Oppenheimer & Co fully exited Celgene Corp in Q4 2019, selling an estimated $6.53M.
  • Oppenheimer & Co's ten largest holdings make up 15% of its $4.04B portfolio in Q4 2019.
  • Oppenheimer & Co opened 108 new positions and closed 87 in Q4 2019.
  • Oppenheimer & Co's portfolio value rose 10% quarter-over-quarter to $4.04B.

Based on Oppenheimer & Co's 13F filing for Q4 2019, filed 7 Feb 2020.